For the patient who presents with a new diagnosis of SLE, or for the one who has a flare in previously established disease, the immediate need is to achieve control of the inflammatory process.

Women with systemic rheumatic diseases (SRDs) commonly report experiencing disease flares and worsening SRD symptoms ...

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

When data from two data sources were analyzed -- one of commercial health insurance claims, the other from Medicare -- ...

Learn how hydroxychloroquine prevents lupus relapses after glucocorticoid withdrawal in inactive SLE patients. Explore ...

When experts have gone looking for evidence that vaccines lead to flares among people with systemic lupus erythematosus (SLE) ...

SLE may not be amenable to a single therapeutic target, but several targets may have to be considered simultaneously, including remission, absence of flares, prevention of damage and minimization ...

The authors of both trials conclude that combined oral contraceptives do not increase the rate or incidence of flare in women with SLE; the risk of thrombosis, however, should still be taken into ...

Some predictors of disease flare have been identified ... they did provide any prognostic information. Two patients with SLE have developed progressive multifocal leukoencephalopathy (PML ...